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The lung cancer mortality rate has been lower in Japan than in
the United States for several decades. We hypothesized that this
difference is due to the Japanese preference for cigarettes with
charcoal-containing filters, which efficiently absorb selected gas
phase components of mainstream smoke including the carcinogen
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. We analyzed a subset
of smokers (396 cases and 545 controls) from a case-control study of
lung cancer conducted in Aichi Prefecture, Japan. The risk associated
with charcoal filters (73% of all subjects) was evaluated after adjusting
for age, sex, education and smoking dose. The odds ratio (OR) associated
with charcoal compared with ‘plain’ cigarette filters was 1.2 (95%
confidence intervals [CI] 0.9, 1.6). The histologic-specific risks were
similar (e.g. OR = 1.3, 95% CI 0.9, 2.1 for adenocarcinoma). The OR
was 1.7 (95% CI 1.1, 2.9) in smokers who switched from ‘plain’ to
charcoal brands. The mean daily number of cigarettes smoked in
subjects who switched from ‘plain’ to charcoal brands was 22.5 and
23.0, respectively. The findings from this study did not indicate that
charcoal filters were associated with an attenuated risk of lung
cancer. As the detection of a modest benefit or risk (e.g. 10–20%)
that can have significant public health impact requires large
samples, the findings should be confirmed or refuted in larger
studies. (Cancer Sci 2005; 96: 283–287)
Most cigarette brands that are manufactured and sold inJapan contain activated carbon (charcoal) granules
embedded in the filter. The charcoal filter efficiently absorbs gas
phase toxins in mainstream smoke including hydrogen cyanide,
formaldehyde, ammonia and crotonaldehyde. Under standard
US Federal Trade Commission (FTC) machine-smoking condi-
tions, selected Japanese cigarettes with charcoal filters delivered
similar yields of carbon monoxide and nicotine but substantially
lower yields of the pulmonary carcinogen 4-(methylnitrosamino)-
1-(3-pyridyl)-1-butanone than selected American filter cigarettes.(1)
The charcoal filter possibly limits the adverse health effects
from smoking, but direct claims of risk reduction have not been
made as empiric evidence is lacking. The charcoal also absorbs
volatiles that flavor the cigarette and consequently the bland
flavor and taste is considered unacceptable to American
consumers. Japanese smokers perceive the taste as smoother
than American brands.(2) Charcoal cigarettes make up <1% of all
cigarette sales in the United States and about 70% in Japan.
(Before 1981 there was no information on sales data in Japan.
Since 1981, the annual market share of charcoal cigarettes has
risen slightly from about 68% to over 70%.)
The higher smoking prevalence in Japanese men compared
with American men, but lower rates and risk of lung cancer, has
long been considered a ‘paradox’.(3−6) It has been suggested that
Japanese cigarettes are less toxic than Western brands. Because
both charcoal filter cigarettes and ‘plain’ filter cigarettes are
smoked in Japan, we determined the risk of lung cancer associated
with filter type in a Japanese population. The overall methods
for this study were described previously.(5)
Materials and Methods
Subject recruitment. We conducted a case-control study of
cigarette smoking and lung cancer in Aichi Prefecture, the third
largest metropolitan area in Japan. Aichi Prefecture has over
five million residents, including two million in its largest city,
Nagoya, and 300 000 in Okazaki City.(7) The Aichi Cancer Center,
National Nagoya Hospital, First Red Cross Hospital, Aichi
Prefecture Hospital and several smaller hospitals recruited
newly diagnosed incident patients with histologically confirmed
lung cancer. The hospital staff, physicians, nurses and study
interviewers identified eligible patients between 1993 and
1998 from surgical schedules and admission rosters. The case
eligibility included an age of 20–81 years, no previous diagnosis
of lung, oral, kidney, bladder or pancreas cancer, and ability to
participate and provide informed consent. The staff abstracted
information on the diagnosis and histology from the pathology
reports and medical records. The response rate was approximately
90%.
The study included both hospital controls and community-
based controls. The eligibility criteria of the two control
groups were the same as for cases except that the hospital
controls were admitted for non-malignant diseases or conditions
unrelated to cigarette smoking. A patient with a non-tobacco-
related cancer was selected only if there were no other available
control. The controls were identified from admission rosters
and matched to cases by age (within 5 years), sex, hospital and
date of interview (±4 months). The patient’s physician was
contacted to obtain consent for the interview. The controls
were grouped by ICD-9 code categories. These included
genitourinary system disorders such as kidney calculus and
renal failure (37% of controls), digestive system disorders such
as hernia, cholelithiasis and cirrhosis (16%), symptoms, signs
and ill-defined conditions (13%), injuries and poisoning (11%),
musculoskeletal and connective tissue diseases (11%), diabetes
and other endocrine disorders (6%), nervous system disorders
(4%) and cancer (2%). The response rate was approximately
90% but because physician consent was not obtained for all
controls, the sample size of hospital controls was smaller than
that for cases.(5)
We selected community controls using a stratified sampling
scheme that was based on the age (within 5 years), sex and
residential district of the hospital where the cases were admitted.
Within each stratum, two controls were selected randomly from
the Aichi Prefecture electoral records that are kept in Nagoya
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and Okazaki City. Each electoral record includes name, mailing
address and birth date. The interviewers placed telephone calls
to enlist participation. The telephone numbers were obtained
from the information service of the telephone company. Forty
percent of the community controls were interviewed. The same
study interviewer assigned to a case patient made an appoint-
ment to visit the control subject at home.
All subjects signed an informed consent form that was approved
by their respective hospital’s Institutional Review Board. After
consent was obtained, subjects were interviewed in person using
a structured questionnaire that contained detailed items on
smoking history including cigarette brand, years of smoking,
cigarettes per day (cpd) and year of smoking cessation.
Statistical analysis. This analysis included subjects who reported
smoking cigarettes regularly, defined as at least one cigarette
per day for one or more years. Never smokers were excluded.
The sample included 396 cases, 224 hospital controls and
321 community controls. The cigarette box label identifies
whether the brand is manufactured with a charcoal filter. Of
1133 ever smokers, 941 (82.7%) of the current and former
smokers reported that their most recent brand was a filter
cigarette (82.7%). One hundred and ninety-two (17.3%) reported
that their most recent brand was a non-filter cigarette or could
not identify the filter type. These subjects were not included in
the analysis.
Univariate analysis of the data included means and standard
deviations. Odds ratios (OR) and 95% confidence intervals (CI)
were derived from unconditional logistic regression analysis.
The main effect variable was coded as ‘1’ for charcoal filters
and ‘0’ for ‘plain’ cigarettes. The OR were adjusted for sex, age,
education, smoking status and pack-years of smoking. We also
modeled the risk adjusted for sex, age, education and years
since quitting smoking. In the latter analysis, index variables
were created for years since quitting smoking (<5, 6–10, 11–20
and >20), with current smokers serving as the referent group.
Histologic-specific risks were calculated using smoking and
other information from the entire control group. All statistical
tests were two-sided.
For subjects who smoked more than one brand in their life-
time, we carried out an analysis based on the two most recent
types of cigarettes smoked. The main effect variables were clas-
sified as ‘charcoal only’ or ‘mixed’ (e.g. charcoal and ‘plain’).
The referent group was ‘plain only.’ Those subjects who
reported that their most recent brand was a filter cigarette but
that their second most recent brand was a non-filter cigarette
were further excluded.
Results
The distribution of sex, age, education and smoking history
are shown in Table 1. Almost 90% of both cases and controls
were men, reflecting the historically low prevalence of smoking
among Japanese women. The average age was approximately
61 years in cases and 60 years in controls, Controls had a higher
mean level of education. Seventy-five percent of cases, 60% of
hospital controls and 55% of community controls were current
smokers. The most common histopathologic types of lung
cancer were adenocarcinoma (43%), squamous cell carcinoma
(28%) and small cell carcinoma (23%).
The characteristics of the subjects were compared by ci-
garette filter type and are shown in Table 2. For 680 subjects
(73%), the most recent brand of cigarette was a charcoal brand
whereas for 257 subjects (27%) it was a ‘plain’ brand. Data on
cigarette amount was missing for four subjects. Current smokers
were more likely to smoke charcoal brands than former smokers.
There were few differences in filter preference by sex, age and
education (Table 2).
The overall OR associated with the most recent brand of
cigarette was 1.2 (95% CI 0.9, 1.6, Table 3) for charcoal versus
‘plain’. The OR was 1.1 (95% CI 0.7, 1.7) when the analysis
was limited to cases and hospital controls only, and 1.3 (95% CI
0.9, 1.9) when the analysis was limited to cases and community
controls only. In a model that substituted years since quitting
for pack-years and smoking status, the overall OR associated
with charcoal filter versus ‘plain’ filter was 1.1 (95% CI 0.8,
1.6; Table 3). In an analysis limited to men only, the OR for
charcoal filter versus ‘plain’ filter was 1.1 (95% CI 0.8, 1.6). In
histologic-specific analyses, the risk associated with charcoal
versus ‘plain’ filter of the most recent brand of cigarette was 1.3
(95% 0.9–2.1) for adenocarcinoma, 1.2 (95% CI 0.7, 2.1) for
squamous cell carcinoma, and 0.6 (95% CI 0.4, 1.1) for small
cell carcinoma (Table 3).
In an examination of the two most recent cigarette brands
smoked, 198 of the 941 smokers of filter cigarettes smoked a
non-filter brand previously. Of the remaining 743, 361 were
classified as smoking charcoal brands only (this number includes
45 subjects whose smoking history was only one brand of char-
coal cigarette), 259 smoked both ‘plain’ and charcoal brands,
and 123 smoked ‘plain’ brands (this number includes 44 sub-
jects whose smoking history was only one brand of ‘plain’
cigarettes). Subjects who smoked both charcoal and plain brands
were classified as ‘switchers.’ In the majority of cases, the
switchers were smokers who changed from smoking a ‘plain’






n = 396 (%)
Hospital controls




Men 348 (87.9) 201 (89.7) 280 (87.2)
Women 48 (12.1) 23 (10.3) 41 (12.8)
Mean age in years 61.5 ± 9.9 57.0 ± 10.1 61.6 ± 10.0
Mean years of education 11.1 ± 2.9 11.8 ± 2.9 12.0 ± 2.9
Smoking status
Current 297 (75.0) 135 (60.3) 177 (55.1)
Former 99 (25.0) 89 (39.7) 144 (44.9)
Histology
Adenocarcinoma 168 (42.5)
Squamous cell carcinoma 109 (27.6)
Small cell carcinoma 91 (23.0)
Other/mixed 28 (6.9%)
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brand to a charcoal brand. Only 32 subjects switched from a
charcoal to a ‘plain’ brand. Many switchers had a history of
smoking three brands. In nearly all cases, the third most recent
brand was also a ‘plain’ cigarette. Only nine subjects reported
switching from a charcoal to a ‘plain’ back to a charcoal brand.
Excluding the subjects whose second previous brand was a
non-filter cigarette, the overall OR for the last two brands was
1.4 (95% CI 0.8, 2.2) for charcoal only versus ‘plain’ only, and
1.7 (95% CI 1.1, 2.9) for mixed versus ‘plain’ only (Table 3).
Similar findings were observed in separate analyses using hos-
pital controls only and community controls only (data not
shown). A significant increased risk for adenocarcinoma of the
lung was observed in subjects who switched from ‘plain’ to
charcoal versus subjects whose last two brands were ‘plain’
cigarettes (Table 3).
The mean number of cigarettes per day in smokers who
smoked two or more brands is shown separately for subjects
who smoked charcoal brands only, mixed smokers, and ‘plain’
brands only (Table 4). The mean number of cigarettes smoked
per day was 27.2 for charcoal brands and 24.3 for ‘plain’
brands. For smokers of charcoal brands that had switched from
a previous brand, the mean number of cigarettes smoked per day
increased by approximately one to two, regardless of the filter
type of the previous brand.
Discussion
The introduction of filter cigarettes into the US market
approximately 50 years ago was anticipated to reduce the future
incidence rate of lung cancer. There are conflicting findings on
whether this occurred in smokers who switched from high-tar
cigarettes to low-tar cigarettes.(8) In Japan, the risk of lung
cancer for those who smoked filter cigarettes all their life
compared with subjects who smoked both non-filter and filter
cigarettes was 0.70 (95% CI 0.4–1.2).(9) These findings indicate
that while filtration substantially reduces exposure to tobacco
carcinogens, the possible benefits might be lower than anticipated
because of compensatory smoking behaviors.
Another technological approach to reduce the hazards from
smoking is the development of a more efficient filtration system
than that provided by a typical acetate filter.(10) The charcoal
filter reduces exposure to several gas phase volatile compounds
under FTC machine-smoking conditions. Selected Japanese
charcoal brands deliver 30% lower yields of both tar and CO,





Charcoal n = 304 (%) ‘Plain’ n = 92 (%) Charcoal n = 379 (%) ‘Plain’ n = 166 (%)
Sex
Men 261 (85.9) 87 (94.6) 331 (87.3) 150 (90.4)
Women 43 (14.1) 5 (5.4) 48 (12.7) 16 (9.6)
Mean age in years 61.2 ± 10.0 62.6 ± 9.5 58.8 ± 10.3 61.6 ± 9.4
Mean years of education 11.0 ± 2.6 11.2 ± 3.5 11.9 ± 2.9 12.0 ± 2.8
Smoking status
Current 235 (77.3) 62 (67.4) 257 (67.8) 55 (33.1)
Former 69 (22.7) 30 (32.6) 122 (32.2) 111 (66.9)
Cigarettes per day 28.3 ± 15.1 31.6 ± 16.4 24.9 ± 14.7 25.5 ± 17.4
Based on the most recent brand of cigarette.




All AC SCC SmCC 
OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Most recent brand (n = 941)
‘Plain’ 1.0 1.0 1.0 1.0
Charcoal 1.2 0.9, 1.6 1.3 0.9, 2.1 1.2 0.7, 2.1 0.6 0.4, 1.1
Last two brands (n = 743)
‘Plain’ only 1.0 1.0 1.0 1.0
Mixed 1.7 1.1, 2.9 2.1 1.1, 4.0 2.5 1.0, 6.3 0.6 0.3, 1.5
Charcoal only 1.4 0.8, 2.2 1.6 0.8, 3.1 1.6 0.6, 4.1 0.6 0.3, 1.3
Odds ratios were adjusted for sex, age, education, smoking status (current vs former) and pack-years. The odds ratio was 1.1 (95% CI 0.8–1.6) after 
adjustment for sex, age, education, cigarette amount and years since quitting. Odds ratios associated with the last two brands of cigarettes were based 
on 743 subjects (includes 654 subjects who smoked two brands, 45 subjects who smoked only one brand of charcoal and were classified as charcoal 
only, and 44 subjects who smoked only one brand of ‘plain’ cigarettes and were classified as ‘plain’ only). AC, adenocarcinoma; SCC, squamous cell 
carcinoma; SmCC, small cell carcinoma.
Table 4. Average number of cigarettes smoked per day (cpd) for the two most recent brands
 
 
Cigarette history Filter type n cpd Filter type n cpd
Most recent brand Charcoal 543 27.2 ± 15.0 ‘Plain’ 111 24.3 ± 13.9
Previous brand ‘Plain’ 220 25.1 + 13.0 Charcoal 32 25.0 ± 12.2
Charcoal 316 26.1 ± 13.8 ‘Plain’ 78 24.0 ± 14.6
A few subjects had missing data for cpd on the previous brand smoked.
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25% lower benzo(a)pyrene (8.5 vs 11.4 ng/cig), 58% lower
tobacco-specific nitrosamines (245 vs 580 ng/cig) and similar
levels of nicotine.(1) Some disadvantages of the charcoal filter
compared with typical acetate filters are increased gas phase
concentration of the lung carcinogen isoprene, possibly
increased production of reactive free radicals,(11) and manu-
facturing defects that contaminate the filter surfaces with charcoal
granules.(12)
The delivery of tobacco smoke toxins from cigarettes with
acetate filters tends to be greater under human smoking condi-
tions than FTC machine-smoking conditions. These compar-
isons have not been conducted for charcoal cigarettes but suggest
that the reduction in gas phase components associated with the
charcoal filter might not be as high as under machine-smoking
conditions. Within a single charcoal cigarette the levels of de-
livered toxins are much higher in the last puffs because the char-
coal becomes inactive and deabsorbs gas phase compounds.(11)
Consequently, the possible impact of charcoal filters on lung
cancer risk might be affected by smoking behaviors such as
number of puffs per cigarette and puff volume. Because the
charcoal filter technology varies from brand to brand and is
under continuous technological development,(13) the filtration
efficiency, taste, aftertaste and possibly puffing habits might
vary from one brand to another.
The current study did not find a reduced risk of lung cancer
associated with charcoal filters. The strengths of our study
included the high response rate in cases and hospital controls, a
similar histologic distribution of lung cancer to that reported in
a prospective study(14) and a similar percentage of subjects that
smoked charcoal filter cigarettes as that reported in national
sales data. The daily smoking amount increased slightly from
the previous brand to the current brand, which is consistent with
Japanese cigarette consumption statistics that show small annual
increases in the average cpd.(15,16)
One limitation was that, as expected, the response rate among
the community controls was lower than for hospital controls,
although not atypical for elderly Japanese citizens contacted by
telephone. The response rate of community controls in a study
of colorectal cancer conducted in Fukuoka, Japan was 60%.(17)
Although the response rate was somewhat lower here, we previ-
ously evaluated response bias for this community control group
and reported few differences in years of smoking and cpd com-
pared to population-based smoking surveys in Japan.(5) The
current analysis also found few differences in the proportion of
community versus hospital controls that smoked charcoal ciga-
rettes. Self-reported smoking information such as cpd, years of
smoking and year started is usually reported accurately. Still,
there is little data on the reliability of self-reported information
on brand name. One study found that the validity of self-
reported cigarette brands was 74%.(18) In this study, the five most
commonly reported brands corresponded to the rankings of
Japanese national sales data (data not shown). Seventeen percent
of subjects reported that the most recent cigarette smoked was a
non-filter brand. This compares to 7.5% reported elsewhere.(9)
However, our data included current and former smokers whereas
Marugame et al. examined current smokers only.(9) The effects of
residual confounding in smokers who switched from non-filter
to filter cigarettes is another potential source of error. We
excluded smokers whose two most recent brands were non-filter
cigarettes but it was not possible to exclude subjects who
smoked a non-filter during their early smoking years.
In summary, charcoal filter tips were not associated with a
reduced lung cancer risk but this finding should be confirmed or
refuted in further investigations because of their potential public
health impact. The charcoal filter is one of several possible
factors that might be associated with the lower smoking-associated
risk of lung cancer in Japan. Other explanations include a lower
baseline risk of lung cancer in Japanese non-smokers than
in American smokers,(6) low saturated fat intake,(19) high fish
consumption(20,21) and high green tea intake.(22) Green tea and other
foods such as black tea and cruciferous vegetables inhibit cyto-
chrome P4502E1 (CYP2E1) activity in vitro and in animals(23)
and may contribute to the lower CYP2E1 activity in Japanese
men than in Caucasian men.(24) Recent data also show that the
1960–1997 lung cancer incidence rates were similar between
Japan and Japanese immigrants to Hawaii after several genera-
tions,(25) despite the lower prevalence of smoking in Japanese
immigrants.(26,27) These data indicate that the Western diet may be
important in explaining ethnic differences in lung cancer. There
is no information on changes in the types of cigarettes preferred
by Japanese immigrants to the US but this information would be
useful in helping to explain these epidemiologic patterns.
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